American Journal of Cardiovascular Drugs

1.1k papers and 17.9k indexed citations i.

About

The 1.1k papers published in American Journal of Cardiovascular Drugs in the last decades have received a total of 17.9k indexed citations. Papers published in American Journal of Cardiovascular Drugs usually cover Cardiology and Cardiovascular Medicine (736 papers), Surgery (350 papers) and Endocrinology, Diabetes and Metabolism (222 papers) specifically the topics of Atrial Fibrillation Management and Outcomes (189 papers), Lipoproteins and Cardiovascular Health (188 papers) and Blood Pressure and Hypertension Studies (164 papers). The most active scholars publishing in American Journal of Cardiovascular Drugs are Gillian M. Keating, Lesley J. Scott, Deepak L. Bhatt, Inmaculada Hernandez and Caroline M. Perry.

In The Last Decade

Fields of papers published in American Journal of Cardiovascular Drugs

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in American Journal of Cardiovascular Drugs. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in American Journal of Cardiovascular Drugs

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in American Journal of Cardiovascular Drugs. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in American Journal of Cardiovascular Drugs with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025